These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15377745)

  • 1. Cerebral perfusion response to successful treatment of depression with different serotoninergic agents.
    Vlassenko A; Sheline YI; Fischer K; Mintun MA
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):360-3. PubMed ID: 15377745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression.
    Hanada H; Imanaga J; Yoshiiwa A; Yoshikawa T; Tanaka Y; Tsuru J; Inoue A; Ishitobi Y; Okamoto S; Kanehisa M; Maruyama Y; Ninomiya T; Higuma H; Isogawa K; Kawasaki T; Fujioka T; Akiyoshi J
    Int J Geriatr Psychiatry; 2013 Jul; 28(7):756-65. PubMed ID: 23007970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor.
    Seedat S; Warwick J; van Heerden B; Hugo C; Zungu-Dirwayi N; Van Kradenburg J; Stein DJ
    J Affect Disord; 2004 May; 80(1):45-53. PubMed ID: 15094257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Brain Perfusion Is Associated with Endothelial Dysfunction Markers in Major Depressive Disorder.
    Massardo T; Quintana JC; Jaimovich R; Sáez CG; Risco L; Liberman C; Araya AV; Galleguillos T; Castro-Mora G; Pereira J
    Neuropsychobiology; 2021; 80(3):214-224. PubMed ID: 32726779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder.
    Massardo T; Quintana JC; Risco L; Corral S; Spuler J; Vicentini D; Castro-Muñoz G; Riedel B; Villa C; Pereira JI
    Neuropsychobiology; 2022; 81(4):271-285. PubMed ID: 35093946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
    Meyer JH
    J Psychiatry Neurosci; 2007 Mar; 32(2):86-102. PubMed ID: 17353938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
    Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
    Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.
    Pålhagen SE; Ekberg S; Wålinder J; Granérus AK; Granerus G
    J Neurol; 2009 Sep; 256(9):1510-8. PubMed ID: 19430931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in regional cerebral blood flow following antidepressant treatment in late-life depression.
    Ishizaki J; Yamamoto H; Takahashi T; Takeda M; Yano M; Mimura M
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):805-11. PubMed ID: 18214999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.
    Wang L; Xia M; Li K; Zeng Y; Su Y; Dai W; Zhang Q; Jin Z; Mitchell PB; Yu X; He Y; Si T
    Hum Brain Mapp; 2015 Feb; 36(2):768-78. PubMed ID: 25332057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.
    Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH
    Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different functioning of prefrontal cortex predicts treatment response after a selective serotonin reuptake inhibitor treatment in patients with major depression.
    Masuda K; Nakanishi M; Okamoto K; Kawashima C; Oshita H; Inoue A; Takita F; Izumi T; Ishitobi Y; Higuma H; Kanehisa M; Ninomiya T; Tanaka Y; Akiyoshi J
    J Affect Disord; 2017 May; 214():44-52. PubMed ID: 28266320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.